These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing. Schinkel AF; Elhendy A; Biagini E; van Domburg RT; Valkema R; Rizello V; Pedone C; Simoons M; Bax JJ; Poldermans D J Nucl Med; 2005 Jan; 46(1):12-8. PubMed ID: 15632027 [TBL] [Abstract][Full Text] [Related]
10. Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography. Boiten HJ; van der Sijde JN; Ruitinga PR; Valkema R; Geleijnse ML; Sijbrands EJ; van Domburg RT; Schinkel AF J Nucl Cardiol; 2012 Oct; 19(5):907-13. PubMed ID: 22875719 [TBL] [Abstract][Full Text] [Related]
11. Eleven-year prognostic value of dobutamine stress (99m)Tc-sestamibi myocardial perfusion imaging in patients with limited exercise capacity. Boiten HJ; van Domburg RT; Valkema R; Schinkel AF Am J Cardiol; 2015 Apr; 115(7):884-9. PubMed ID: 25661571 [TBL] [Abstract][Full Text] [Related]
12. Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease. Soman P; Taillefer R; DePuey EG; Udelson JE; Lahiri A J Am Coll Cardiol; 2001 Feb; 37(2):458-62. PubMed ID: 11216963 [TBL] [Abstract][Full Text] [Related]
13. Efficiency comparison between 99m Tc-tetrofosmin and 99m Tc-sestamibi myocardial perfusion studies. Ravizzini GC; Hanson MW; Shaw LK; Wong TZ; Hagge RJ; Pagnanelli RA; Jain D; Lima HS; Coleman RE; Borges-Neto S Nucl Med Commun; 2002 Mar; 23(3):203-8. PubMed ID: 11891477 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of automated quantification of 99mTc-sestamibi myocardial perfusion imaging. Leslie WD; Tully SA; Yogendran MS; Ward LM; Nour KA; Metge CJ J Nucl Med; 2005 Feb; 46(2):204-11. PubMed ID: 15695777 [TBL] [Abstract][Full Text] [Related]
15. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease. Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532 [TBL] [Abstract][Full Text] [Related]
16. Combined supine and prone myocardial perfusion single-photon emission computed tomography with a cadmium zinc telluride camera for detection of coronary artery disease. Nishiyama Y; Miyagawa M; Kawaguchi N; Nakamura M; Kido T; Kurata A; Kido T; Ogimoto A; Higaki J; Mochizuki T Circ J; 2014; 78(5):1169-75. PubMed ID: 24572492 [TBL] [Abstract][Full Text] [Related]
17. Long-term prognostic value of dobutamine stress 99mTc-sestamibi SPECT: single-center experience with 8-year follow-up. Schinkel AF; Elhendy A; Van Domburg RT; Bax JJ; Valkema R; Roelandt JR; Poldermans D Radiology; 2002 Dec; 225(3):701-6. PubMed ID: 12461248 [TBL] [Abstract][Full Text] [Related]
18. Comparative myocardial uptake of technetium-99 m sestamibi and technetium-99m tetrofosmin one hour after stress injection. Gremillet E; Champailler A Eur J Nucl Med; 1998 Nov; 25(11):1502-10. PubMed ID: 9799346 [TBL] [Abstract][Full Text] [Related]
19. The effect of imaging time, radiopharmaceutical, full fat milk and water on interfering extra-cardiac activity in myocardial perfusion single photon emission computed tomography. Peace RA; Lloyd JJ Nucl Med Commun; 2005 Jan; 26(1):17-24. PubMed ID: 15604943 [TBL] [Abstract][Full Text] [Related]
20. Technetium-99m sestamibi and tetrofosmin myocardial single-photon emission tomography: can we use the same reference data base? Widding A; Hesse B; Gadsboll N Eur J Nucl Med; 1997 Jan; 24(1):42-5. PubMed ID: 9044875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]